Axa Ebit Per Revenue from 2010 to 2024

EQH Stock  USD 41.49  0.01  0.02%   
Axa Equitable's Ebit Per Revenue is decreasing with slightly volatile movements from year to year. Ebit Per Revenue is estimated to finish at 0.08 this year. For the period between 2010 and 2024, Axa Equitable, Ebit Per Revenue quarterly trend regression had median of  0.14 and r-value of (0.44). View All Fundamentals
 
Ebit Per Revenue  
First Reported
2010-12-31
Previous Quarter
0.07831374
Current Value
0.0822
Quarterly Volatility
0.15578489
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Axa Equitable financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Axa main balance sheet or income statement drivers, such as Depreciation And Amortization of 565.3 M, Interest Expense of 174.7 M or Selling General Administrative of 2.4 B, as well as many exotic indicators such as Price To Sales Ratio of 0.79, Dividend Yield of 0.022 or PTB Ratio of 4.62. Axa financial statements analysis is a perfect complement when working with Axa Equitable Valuation or Volatility modules.
  
This module can also supplement Axa Equitable's financial leverage analysis and stock options assessment as well as various Axa Equitable Technical models . Check out the analysis of Axa Equitable Correlation against competitors.

Latest Axa Equitable's Ebit Per Revenue Growth Pattern

Below is the plot of the Ebit Per Revenue of Axa Equitable Holdings over the last few years. It is Axa Equitable's Ebit Per Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Axa Equitable's overall financial position and show how it may be relating to other accounts over time.
Ebit Per Revenue10 Years Trend
Slightly volatile
   Ebit Per Revenue   
       Timeline  

Axa Ebit Per Revenue Regression Statistics

Arithmetic Mean0.08
Coefficient Of Variation198.50
Mean Deviation0.12
Median0.14
Standard Deviation0.16
Sample Variance0.02
Range0.4974
R-Value(0.44)
Mean Square Error0.02
R-Squared0.20
Significance0.1
Slope(0.02)
Total Sum of Squares0.34

Axa Ebit Per Revenue History

2024 0.0822
2023 0.0783
2021 -0.12
2020 -0.16
2019 -0.3
2018 0.2
2017 0.084

About Axa Equitable Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Axa Equitable income statement, its balance sheet, and the statement of cash flows. Axa Equitable investors use historical funamental indicators, such as Axa Equitable's Ebit Per Revenue, to determine how well the company is positioned to perform in the future. Although Axa Equitable investors may use each financial statement separately, they are all related. The changes in Axa Equitable's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Axa Equitable's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Axa Equitable Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Axa Equitable. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Ebit Per Revenue 0.08  0.08 

Currently Active Assets on Macroaxis

When determining whether Axa Equitable Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Axa Equitable's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Axa Equitable Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Axa Equitable Holdings Stock:
Check out the analysis of Axa Equitable Correlation against competitors.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Complementary Tools for Axa Stock analysis

When running Axa Equitable's price analysis, check to measure Axa Equitable's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Axa Equitable is operating at the current time. Most of Axa Equitable's value examination focuses on studying past and present price action to predict the probability of Axa Equitable's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Axa Equitable's price. Additionally, you may evaluate how the addition of Axa Equitable to your portfolios can decrease your overall portfolio volatility.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Stocks Directory
Find actively traded stocks across global markets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Is Axa Equitable's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axa Equitable. If investors know Axa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axa Equitable listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.33)
Dividend Share
0.9
Earnings Share
3.33
Revenue Per Share
30.362
Quarterly Revenue Growth
(0.05)
The market value of Axa Equitable Holdings is measured differently than its book value, which is the value of Axa that is recorded on the company's balance sheet. Investors also form their own opinion of Axa Equitable's value that differs from its market value or its book value, called intrinsic value, which is Axa Equitable's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axa Equitable's market value can be influenced by many factors that don't directly affect Axa Equitable's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axa Equitable's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axa Equitable is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axa Equitable's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.